SMTL ID : 6qtj.1

Crystal structure of human CDK8/CYCC in complex with BI 919811

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.48 Å

Oligo State

hetero-1-1-mer

Ligands

1 x JHK: ~{N},~{N}-dimethyl-2-[4-[4-(2,6-naphthyridin-4-yl)phenyl]pyrazol-1-yl]ethanamide(Non-covalent)

JHK.1: 14 residues within 4Å: Chain A: V.29, G.30, R.31, V.37, A.52, I.81, F.99, D.100, Y.101, A.102, D.105, H.108, L.160, R.358 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.37, A:A.52, A:I.81, A:F.99, A:L.160, A:L.160 Hydrogen bonds: A:R.31, A:A.102 pi-Stacking: A:H.108 pi-Cation interactions: A:R.358

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Hofmann, M.H. et al., Selective and Potent CDK8/19 Inhibitors Enhance NK-Cell Activity and Promote Tumor Surveillance. Mol.Cancer Ther. (2020)

Release Date

2020-03-18

Peptides

Cyclin-dependent kinase 8: A
Cyclin-C: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Cyclin-dependent kinase 8

Cyclin-C

Related Entries With Identical Sequence